Ping An Healthcare and Technology Full Year 2022 Earnings: EPS Beats Expectations, Revenues Lag

Ping An Healthcare and Technology (HKG:1833) Full Year 2022 Results

Key Financial Results

• Revenue: CN¥6.16b (down 16% from FY 2021).
• Net loss: CN¥607.6m (loss narrowed by 61% from FY 2021).
• CN¥0.56 loss per share (improved from CN¥1.40 loss in FY 2021).

All figures shown in the chart above are for the trailing 12 month (TTM) period

Ping An Healthcare and Technology EPS Beats Expectations, Revenues Fall Short

Revenue missed analyst estimates by 3.6%. Earnings per share (EPS) exceeded analyst estimates by 38%.

Looking ahead, revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Online Retail industry in Hong Kong.

Performance of the Hong Kong Online Retail industry.

The company's shares are down 2.4% from a week ago.

Balance Sheet Analysis

Just as investors must consider earnings, it is also important to take into account the strength of a company's balance sheet. See our latest analysis on Ping An Healthcare and Technology's balance sheet health.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.